ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,492Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 939

$1.75M Total Retail Price of All Prescriptions

Rank: 6 out of 939

803 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

22% of this provider’s 803 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 803 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 23,117 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
FUROSEMIDE 1,145 1,031 1 7
LEVOTHYROXINE SODIUM 809 712 2 4
POTASSIUM CHLORIDE 760 673 3 9
WARFARIN SODIUM 680 585 4 17
QUETIAPINE FUMARATE 678 621 5 69
LISINOPRIL 640 517 6 3
SIMVASTATIN 631 531 7 2
OXYCODONE HCL 619 409 S2 8 67
GABAPENTIN 589 430 9 11
CITALOPRAM HBR 549 510 10 15
OMEPRAZOLE 479 432 11 5
CARVEDILOL 453 409 12 25
NAMENDA 442 437 13 49
DONEPEZIL HCL 431 421 14 30
DIVALPROEX SODIUM 406 375 15 95
METOPROLOL TARTRATE 400 363 16 10
AMLODIPINE BESYLATE 389 366 17 6
MIRTAZAPINE 354 339 18 56
TAMSULOSIN HCL 343 291 19 27
ISOSORBIDE MONONITRATE ER 337 309 20 53
METFORMIN HCL 310 240 21 8
TRAMADOL HCL 282 217 22 16
HYDROCODONE-ACETAMINOPHEN 281 241 S3 23 1
RISPERIDONE 269 264 24 82
FAMOTIDINE 243 223 25 62
SPIRONOLACTONE 221 174 26 71
ATENOLOL 220 175 27 19
SEROQUEL 217 208 28 139
CLOPIDOGREL 214 189 29 28
ATORVASTATIN CALCIUM 200 173 30 22
DIOVAN 196 183 31 50
EXELON 195 174 32 151
OLANZAPINE 192 182 33 135
LANTUS 188 175 34 59
METOPROLOL SUCCINATE 182 173 35 21
CYMBALTA 172 76 36 44
PAROXETINE HCL 171 140 37 70
CARBIDOPA-LEVODOPA 165 156 38 102
DIGOXIN 165 137 38 45
DIVALPROEX SODIUM ER 163 118 40 146
CIPROFLOXACIN HCL 160 143 41 54
GLIPIZIDE 160 120 41 52
HYDROCHLOROTHIAZIDE 158 125 43 12
NEXIUM 157 88 44 18
ESCITALOPRAM OXALATE 155 136 45 61
FENTANYL 155 103 S2 45 104
ALLOPURINOL 154 148 47 31
MORPHINE SULFATE ER 143 72 S2 48 113
FENOFIBRATE 137 119 49 83
PLAVIX 137 128 49 48
HALOPERIDOL 129 85 51 169
RANITIDINE HCL 126 101 52 35
TRAZODONE HCL 120 99 53 26
SERTRALINE HCL 114 104 54 24
ZOLPIDEM TARTRATE 113 60 55 20
ROPINIROLE HCL 111 109 56 78
PRAVASTATIN SODIUM 110 105 57 13
NOVOLOG 110 98 57 145
ALENDRONATE SODIUM 109 97 59 40
ADVAIR DISKUS 108 92 60 60
AMIODARONE HCL 107 105 61 160
IPRATROPIUM-ALBUTEROL 106 106 62 178
POLYETHYLENE GLYCOL 3350 104 81 63 57
TRIAMTERENE-HCTZ 104 102 63 33
OXYBUTYNIN CHLORIDE ER 99 98 65 167
ABILIFY 99 40 65 156
SPIRIVA 98 88 67 73
NITROFURANTOIN MONO-MACRO 97 93 68 180
OXYCONTIN 96 62 S2 69 161
LYRICA 95 54 70 63
ALBUTEROL SULFATE 95 94 70 171
CYCLOBENZAPRINE HCL 95 45 R 70 36
LOSARTAN POTASSIUM 94 88 73 29
AMITRIPTYLINE HCL 92 67 R 74 38
OXCARBAZEPINE 89 66 75 227
PREDNISONE 89 74 75 42
LANTUS SOLOSTAR 88 58 77 128
PROMETHAZINE HCL 86 29 R 78 68
CRESTOR 84 84 79 34
MEGACE ES 84 80 R 79 326
CEFTRIAXONE 82 76 81 197
SULFAMETHOXAZOLE-TRIMETHOPRIM 82 70 81 64
AMOXICILLIN 82 68 81 92
FLUOXETINE HCL 79 56 84 47
MORPHINE SULFATE 79 46 S2 84 186
VESICARE 78 63 86 202
PHENYTOIN SODIUM EXTENDED 77 24 87 99
KLOR-CON M20 76 58 88 90
NOVOLIN R 75 58 89 217
DOXYCYCLINE HYCLATE 75 64 89 84
NAPROXEN 73 64 91 72
NYSTATIN 73 66 91 174
AZITHROMYCIN 70 66 93 32
LIDODERM 70 47 93 257
FINASTERIDE 69 60 95 131
CLONIDINE HCL 68 59 96 39
OXYBUTYNIN CHLORIDE 68 41 96 125
GLIPIZIDE ER 67 56 98 88
MEGESTROL ACETATE 67 56 R 98 136
SUCRALFATE 64 58 100 96
SYMBICORT 63 62 101 137
LEVEMIR 63 61 101 168
LATANOPROST 63 48 101 233
RANEXA 63 63 101 248
BENZTROPINE MESYLATE 59 42 R 105 175
TRIAMCINOLONE ACETONIDE 58 53 106 150
CARBAMAZEPINE 57 38 107 189
ACTOS 57 30 107 141
JANUVIA 57 40 107 110
FLUTICASONE PROPIONATE 56 54 110 43
PROAIR HFA 56 32 110 41
NYSTOP 56 54 110 289
LIDOCAINE HCL 54 49 113 223
LIPITOR 53 50 114 127
MEDROXYPROGESTERONE ACETATE 53 14 114 321
BACLOFEN 51 42 116 157
LEVOFLOXACIN 51 44 116 86
ONDANSETRON HCL 50 45 118 291
PRIMIDONE 50 37 118 228
HYDRALAZINE HCL 50 31 118 130
DILTIAZEM 24HR CD 50 41 118 126
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.